Auto-HCT produces ‘very deep, robust remissions’ in AL amyloidosis

Healio spoke withTaimur Sher, MBBS, MD,a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, about the effects and potential intolerance issues of auto-hematopoietic stem cell transplantation in amyloid light chain (AL) amyloidosis patients.

Watch the video for more on what’s in the pipeline for AL amyloidosis.